nivolumab,ipilimumab
bms
['unison', 'nivo', 'renal,(-adrenal)', 'rcc,(-irccs),(-srcc),(-urcc)', 'anzup 1602', 'nivolumab', 'ipilimumab']
sequential immunotherapy in rare variant #rcc final report of #unison (anzup 1602): nivolumab then ipilimumab + nivolumab in advanced non-clear cell #renalcellcarcinoma. presentation by . #asco22 written coverage &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology